Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
13.50    0.00 (0.00%)
Bid:
13.25
Ask:
13.75
Spread: 0.50 (3.774%)
Market Cap: £65.58m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

Directorate Change

29 Jun 2009 07:00

RNS Number : 6190U
China Real Estate Opportunities PLC
29 June 2009
 



CHINA REAL ESTATE OPPORTUNITIES PLC

Board Changes

China Real Estate Opportunities plc ('"CREO" or the "Company"announces the appointment of Richard Anthony David to the Board. Mr David, aged 46, is Managing Director of Treasury Holdings China Limited and based in Shanghai. He has worked in the real estate industry since 1981 and been based in China since 1999. He joined Treasury Holdings China Limited in August 2007 having previously been Head of China Real Estate for Macquarie Bank Limited of Australia.

The Directors would also like to announce that Mr Robert Tincknell, non-executive Director of the Company, has resigned from the Board to take up a Directorship with Real Estate Opportunities plc ("REO"). Mr Tincknell was previously based in Shanghai and held the position of Managing Director in Treasury Holdings China Limited until early 2008 when he returned to the UK to take up the position of Managing Director of Treasury Holdings UK assuming operational responsibility for the UK activities of REO.

As with all appointments to the board of the Company, Mr David's appointment is subject to consent from the Jersey Regulator. Having regard to the residence of the Directors and the location of the Company's business and assets, The Panel on Takeovers and Mergers has confirmed that, upon Mr David's appointment becoming unconditionalit would no longer regard the Company as one to which the City Code on Takeovers and Mergers would apply.

Ray Horney, Chairman of CREO, commented:

"I would like to thank Rob for his contribution to the Company since its launch and welcome the appointment of Richard to the Board." 

Details of Mr David's directorships in the last five years and current directorships are detailed below:

Past directorships held within the last five years

Past directorships held within the last five years

Anting Investments Limited

Austian (Tianjin) Property Development Co Limited

China Property Investments Limited

First China Property Development Limited

First China Property Group Limited

First China Property Management Limited

Macquarie (Tianjin) Property Services Co. Ltd

Macquarie Hallway Property Limited

Macquarie Jin Lin (Mauritius) Pty Ltd

Macquarie Jin Lin Pty Limited

Macquarie Property China Pty Limited

Macquarie Real Estate Asia Limited

Markgold International Housing and Land Consulting (Beijing) Co Ltd

Markgold International Housing and Land Consulting (Shanghai) Co Ltd

Pasley International Limited

San Ling Investments Limited

Shanghai Anting Waratah Real Estate Development Co, Limited

Shanghai Chengli Properties Co Ltd

Shanghai International Company Limited

Shanghai Pdg Waratah Property Co., Ltd

Tianjin Macquarie Property Development Management Co Limited 

Current directorships

Shanghai Huatian Property Development Co., Ltd 

Shanghai Central Land Property Co., Ltd

Shanghai Vision Honest Real Estate Development Co., Ltd

Beijing Dream Land Industrial Development Co., Ltd

Beijing Treasury Industrial Development Co., Ltd

Qingdao Shangshi CREO Real Estate Co., Ltd 

Qingdao CREO Logistics Park Co., Ltd

Nanjing CREO Investment Consulting Co., Ltd

Treasury (Shanghai) Real Estate Consulting Co., Ltd

Treasury Holdings (Shanghai) Property Management Co., Ltd

Treasury Holdings China Limited Qingdao Rep. Office

Treasury Holdings Real Estate (HK) Ltd

Treasury Holdings Limited

Jagard Pty Ltd

There are no further details required to be disclosed in respect of Mr David's appointment pursuant to schedule 2(g) of the AIM rules. 

 

ENDSContact: CREORay Horney, Chairman Tel: + 44 (0)1273 775225 Sarah Moriarty, Investor Relations  Tel: +353 1 6189455 Matrix Corporate CapitalPaul Fincham Tel +44 (0) 203206 7000 DavyDes Carville Tel: +353 1 679 6363 Bankside ConsultantsSimon Rothschild, Oliver Winters Tel: + 44 (0)207 367 8888

Murray ConsultantsEd Micheau Tel: + 3531 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABUGDLBBDGGCL
Date   Source Headline
9th Dec 20207:00 amRNSFirst clinical use of new Creo GI product
24th Nov 20201:36 pmRNSExercise of Options
3rd Nov 20207:00 amRNSAcquisition of Boucart Medical SRL
2nd Nov 20207:00 amRNSUS FDA clearance for MicroBlate™ Fine device
23rd Sep 20207:00 amRNSHalf-year Report
26th Aug 20204:09 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSExercise of Options
3rd Aug 20207:00 amRNSVideo abstract published endorsing Speedboat
24th Jul 202011:00 amRNSDirector/PDMR Shareholding
24th Jul 20207:00 amRNSAcquisition of Albyn Medical S.L.
13th Jul 202010:37 amRNSSecretary of State for Wales site visit
13th Jul 202010:08 amRNSSecretary of State for Wales site visit
6th Jul 20207:00 amRNSDirectorate Change
2nd Jul 20207:00 amRNSDevelopment loan for plasma sterilising product
24th Jun 202010:30 amRNSResult of AGM
15th Jun 20207:00 amRNSCE mark for five new devices
8th Jun 20207:00 amRNSIET Prize nomination
3rd Jun 20207:00 amRNSPositive NHS health economics data
27th May 20207:00 amRNSPosting of Annual Report & Notice of AGM
20th May 20207:00 amRNSCommercialisation Agreement
7th May 20207:00 amRNSFinal Results
23rd Mar 20207:00 amRNSFDA Clearance for HS1 Haemostasis Device
20th Mar 20207:00 amRNSTrading update – COVID-19 impact
4th Mar 20205:00 pmRNSExercise of Options
24th Feb 20203:49 pmRNSHolding(s) in Company
19th Feb 20207:00 amRNSLTIP Awards and Issue of Equity
11th Feb 20207:00 amRNSVideo abstracts re. Speedboat procedures in India
7th Feb 202011:50 amRNSExercise of Options
6th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
3rd Feb 20207:00 amRNSAppointment of NED
30th Jan 20207:00 amRNSTrading update
30th Dec 20193:17 pmRNSHolding(s) in Company
27th Dec 20195:00 pmRNSHolding(s) in Company
24th Dec 20198:01 amRNSDirector/PDMR Shareholding
23rd Dec 201911:15 amRNSResult of General Meeting and Total Voting Rights
23rd Dec 20197:00 amRNSResult of Open Offer
4th Dec 20197:00 amRNSRe. Placing, Open Offer, and Posting of Circular
2nd Dec 20197:00 amRNSFundraising and Launch of Accelerated Book Build
20th Nov 20197:00 amRNSFirst in-human cases in India
22nd Oct 20197:00 amRNSCommercial Launch of Speedboat at UEG Week
17th Oct 20197:00 amRNSUK Endoscopy Training Course
30th Sep 20197:00 amRNSHalf-year Report
26th Sep 20197:00 amRNSFramework Distribution Agreement for India
23rd Sep 20192:16 pmRNSNotice of Results
10th Sep 20197:00 amRNSUS Clinical Education Programme enters Phase II
7th Aug 20191:57 pmRNSDirector/PDMR Shareholding
5th Jul 20197:00 amRNSInstitute of Physics Award
25th Jun 20197:00 amRNSFirst commercial orders for Speedboat
6th Jun 20191:23 pmRNSResult of AGM
13th May 201910:50 amRNSAnnual Reports & Accounts & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.